阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效  

Therapeutic effect of atorvastatin combined with trimetazidine in treatment of coronary heart disease

作　　者：周浩[1] 

机构地区：[1]南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁223800

出　　处：《中国校医》2017年第12期919-921,共3页Chinese Journal of School Doctor

摘　　要：目的观察阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效。方法选取冠心病患者150例,按照随机偶数奇数法分为对照组(75例,曲美他嗪治疗)和治疗组(75例,阿托伐他汀联合曲美他嗪治疗),对2组患者的临床治疗效果进行观察和比较。结果治疗组治疗总有效率、平板运动实验情况、心功能指标、缺血不良事件发生率均优于对照组(P<0.05)。结论阿托伐他汀联合曲美他嗪可显著改善冠心病心功能,提高治疗效果,降低缺血不良事件发生概率,值得在临床中推广应用和全面普及。Objective To evaluate the clinical efficacy of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods A total of 150 patients with coronary heart disease were randomly divided into a control group （75 cases, trimetazidine treatment） and treatment group （75 cases, atorvastatin combined with trimetazidine treatment）. The therapeutic effects of the patients in the two groups were observed and compared. Results The total effective rate, tread- mill exercise test status, cardiac function index and incidence of ischemic adverse events of the treatment group were superior to those of the control group （P 〈0.05）. Conclusion Atorvastatin combined with trimetazidine can significantly improve the cardiac function, improve the treatment effect, and reduce the occurrence probability of ischemic adverse events of the patients with coronary heart disease.

关 键 词：冠状动脉疾病/药物疗法 阿托伐他汀 曲美他嗪/治疗应用 

分 类 号：R541[医药卫生—心血管疾病]